The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under ...

There has been a noticeable shift in the tone across the US over the past several years, escalating in recent months. An intensifying pattern of pervasive anxiety has surfaced among individuals ...

This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several major funding announcements in ...

This week, the Department of Health and Human Services (HHS) underwent a massive restructuring under its secretary Robert F. Kennedy Jr., resulting in the sudden departure of thousands of ...

An experimental Alzheimer’s disease therapy designed by Alzheon to reduce depositions of amyloid plaque in the brain failed to beat a placebo in a Phase 3 study, the latest blow to a drug whose ...